Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Retained Earnings (2016 - 2025)

Iradimed (IRMD) has disclosed Retained Earnings for 13 consecutive years, with $64.2 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 13.1% to $64.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.2 million through Dec 2025, up 13.1% year-over-year, with the annual reading at $64.2 million for FY2025, 13.1% up from the prior year.
  • Retained Earnings for Q4 2025 was $64.2 million at Iradimed, down from $66.3 million in the prior quarter.
  • The five-year high for Retained Earnings was $66.3 million in Q3 2025, with the low at $6127.0 in Q1 2022.
  • Average Retained Earnings over 5 years is $37.6 million, with a median of $43.6 million recorded in 2022.
  • The sharpest move saw Retained Earnings crashed 80.98% in 2022, then skyrocketed 611087.2% in 2023.
  • Over 5 years, Retained Earnings stood at $17012.0 in 2021, then soared by 277729.07% to $47.3 million in 2022, then fell by 8.48% to $43.3 million in 2023, then soared by 31.28% to $56.8 million in 2024, then increased by 13.1% to $64.2 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $64.2 million, $66.3 million, and $62.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.